PLx Pharma (PLXP) Misses Q4 EPS by 2c

PLx Pharma (NASDAQ: PLXP) reported Q4 EPS of ($0.73), $0.02 worse than the analyst estimate of ($0.71). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $2.05 million.

For earnings history and earnings-related data on PLx Pharma (PLXP) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Radnostix revenue falls 27% amid product recalls and FDA actions